113 related articles for article (PubMed ID: 5365416)
1. [Hemodynamic and metabolic technic of study of a drug with cerebrovascular action].
Espagno J; Lazorthes Y; Arbus L
Therapeutique; 1969 Nov; 45(9):888-90. PubMed ID: 5365416
[No Abstract] [Full Text] [Related]
2. [Effects of nicergoline on hemodynamics and metabolism of the brain in primary arterial hypertension and in arteriosclerosis].
Maiolo AT; Bianchi Porro G; Galli C; Sessa M
Clin Ter; 1972 Aug; 62(3):239-52. PubMed ID: 5081153
[No Abstract] [Full Text] [Related]
3. [Pharmacology of brain circulation and clinical extrapolations. An experimental study of the circulatory and metabolic effects of Hydrosarpan 711].
Cahn J; Herold M; Borzeix MG
Sem Hop Ther; 1974 Dec; 50(10):671-82. PubMed ID: 4465918
[No Abstract] [Full Text] [Related]
4. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
Reimann-Hunziker R; Reimann-Hunziker GJ
Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
[No Abstract] [Full Text] [Related]
5. [Action of taurine on initial senile cerebral involution].
Fanciullacci M; Franchi G; Sicuteri F; Suman A
Clin Ter; 1974 Sep; 70(5):425-33. PubMed ID: 4421446
[No Abstract] [Full Text] [Related]
6. The differential effect of ammonium salts on oxygen and glucose consumption by the canine brain.
James IM; Nashat S; Larbi EB; Garassini M
Clin Sci; 1969 Dec; 37(3):877. PubMed ID: 5363589
[No Abstract] [Full Text] [Related]
7. [Effects of pirozadil on metabolic blood flow in brain rabbit (author's transl)].
Balasch J; Palacios L
Arch Farmacol Toxicol; 1977 Aug; 3(2):137-40. PubMed ID: 921334
[No Abstract] [Full Text] [Related]
8. [On the circulatory physiology and biochemistry of cerebral degeneration processes and influencing the behavior of patients with drug therapy].
Cornu F
Wien Klin Wochenschr; 1969 Jun; 81(23):426-31. PubMed ID: 5790194
[No Abstract] [Full Text] [Related]
9. [The effects of high-dose fentanyl on cerebral circulation and metabolism in dogs].
Tada T; Ishidera T; Sakai M; Ichiyanagi K
Masui; 1984 Dec; 33(12):1310-6. PubMed ID: 6530732
[No Abstract] [Full Text] [Related]
10. [Effect of clofelin and apressin on blood circulation and metabolic indices of the brain].
Sankina ZhV; Gaevyĭ MD
Farmakol Toksikol; 1984; 47(5):32-6. PubMed ID: 6500032
[TBL] [Abstract][Full Text] [Related]
11. [Internal therapy of aging processes of the brain and its vessels].
Gottstein U
Wien Klin Wochenschr; 1969 Jun; 81(24):441-6. PubMed ID: 5351157
[No Abstract] [Full Text] [Related]
12. [A new stimulating agent of cerebrovascular circulation].
Moreau P
Nouv Presse Med; 1975 Oct; 4(33):2401-2. PubMed ID: 1105410
[No Abstract] [Full Text] [Related]
13. [Effect of cocarboxylase on cerebral circulation of patients with cerebral arteriosclerosis].
Eninia GI; Smeltere ES
Vrach Delo; 1974 Dec; (12):17-20. PubMed ID: 4446520
[No Abstract] [Full Text] [Related]
14. [Specific features of sodium oxybutyrate and seduxen action on the indices of cerebral circulation in cerebrovascular insufficiency].
Eninia GI; Smeltere ES; Margolina AG; Mennika RK
Klin Med (Mosk); 1977 Oct; 55(10):102-5. PubMed ID: 592685
[No Abstract] [Full Text] [Related]
15. [Effect of phosphobion on the indicators of cerebrovascular circulation].
Eninia GI; Smeltere ES
Vrach Delo; 1976 Feb; (2):21-3. PubMed ID: 1266144
[No Abstract] [Full Text] [Related]
16. [Brain metabolism studies under the treatment with pyrithioxin].
Becker K; Hoyer S
Dtsch Z Nervenheilkd; 1966 Mar; 188(3):200-9. PubMed ID: 5983388
[No Abstract] [Full Text] [Related]
17. Clinical importance of alterations in barrier.
Quadbeck G
Prog Brain Res; 1968; 29():343-8. PubMed ID: 5735115
[No Abstract] [Full Text] [Related]
18. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation].
Danilova IN; Neretin VIa; Nesterova LA
Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (4):13-7. PubMed ID: 7415011
[No Abstract] [Full Text] [Related]
19. [Can disorders of cerebral performance be improved by drugs? Use of vaso- and metabolically active substances in primary degenerative brain diseases and cerebral arteriosclerosis].
Herrschaft H
Fortschr Med; 1987 Nov; 105(32):637-40. PubMed ID: 3323002
[No Abstract] [Full Text] [Related]
20. [The effect of sermion on the main hemodynamic indices in patients with the initial manifestations of cerebral atherosclerosis].
Tokar' AV; Akhaladze NG; Ena LM; Rudaia ES; Severova NL
Vrach Delo; 1990 Feb; (2):27-30. PubMed ID: 2339544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
